NasdaqGS:TLRYPharmaceuticals
Is Tilray Brands' (TLRY) Italian Medical Push Quietly Redefining Its Global Cannabis Strategy?
Earlier in January 2026, Tilray Medical, a division of Tilray Brands, expanded its European medical cannabis operations by launching Tilray Medical Italia, rebranding the former FL Group and broadening an Italian Ministry of Health–authorized product portfolio in partnership with Molteni Farmaceutici.
This move not only deepens Tilray’s presence in one of Europe’s most tightly regulated medical cannabis markets, it also advances its goal of building a unified global medical cannabis platform...